ArticleDiscovery of a Two-Component Monooxygenase SnoaW/SnoaL2 Involved in NOGALAMYCIN (cas 1404-15-5) Biosynthesis

Add time:09/03/2019    Source:sciencedirect.com

SummaryNOGALAMYCIN (cas 1404-15-5) is an anthracycline polyketide antibiotic that contains two deoxysugars, at positions C-1 and C-7. Previous biosynthetic studies conducted in vivo affiliated snoaL2 with an unusual C-1 hydroxylation reaction, but in vitro activity was not established. Here, we demonstrate that inactivation of either snoaL2 or snoaW resulted in accumulation of two nonhydroxylated metabolites, nogalamycinone and a novel anthracycline 3′,4′-demethoxy-nogalose-nogalamycinone. The C-1 hydroxylation activity was successfully reconstructed in vitro in the presence of the two enzymes, NAD(P)H and the substrates. Based on relative reaction efficiencies, 3′,4′-demethoxy-nogalose-nogalamycinone was identified as the likely natural substrate. A biosynthetic model was established where the atypical short-chain alcohol dehydrogenase SnoaW reduces the anthraquinone to a dihydroquinone using NADPH, which enables activation of oxygen and formation of a hydroperoxy intermediate. Finally, protonation of the intermediate by SnoaL2 yields the 1-hydroxylated product.

We also recommend Trading Suppliers and Manufacturers of NOGALAMYCIN (cas 1404-15-5). Pls Click Website Link as below: cas 1404-15-5 suppliers

Prev:Construction of the DEF-ring system of NOGALAMYCIN (cas 1404-15-5) and menogaril via an efficient Suzuki-Miyaura reaction
Next:The biochemical pharmacology of NOGALAMYCIN (cas 1404-15-5) and its derivatives☆)